COMMUNITY HEALTHCARE TRUST I (CHCT) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:CHCT - US20369C1062 - REIT
15.95 USD
+0.18 (+1.14%)
15.95 USD
0 (0%)
We assign a fundamental rating of 3 out of 10 to CHCT. CHCT was compared to 127 industry peers in the Diversified REITs industry. CHCT may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, CHCT is valued expensive at the moment. Finally CHCT also has an excellent dividend rating.
1. Profitability
1.1 Basic Checks
In the past year CHCT has reported negative net income.
CHCT had a positive operating cash flow in the past year.
Of the past 5 years CHCT 4 years were profitable.
In the past 5 years CHCT always reported a positive cash flow from operatings.
1.2 Ratios
With a Return On Assets value of -1.06%, CHCT is not doing good in the industry: 67.97% of the companies in the same industry are doing better.
CHCT has a Return On Equity of -2.46%. This is in the lower half of the industry: CHCT underperforms 67.19% of its industry peers.
The Return On Invested Capital of CHCT (2.27%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CHCT is in line with the industry average of 3.06%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.46% | ||
| ROIC | 2.27% |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
1.3 Margins
The Operating Margin of CHCT (23.26%) is comparable to the rest of the industry.
In the last couple of years the Operating Margin of CHCT has declined.
CHCT has a better Gross Margin (80.68%) than 81.25% of its industry peers.
In the last couple of years the Gross Margin of CHCT has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.26% | ||
| PM (TTM) | N/A | ||
| GM | 80.68% |
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CHCT is destroying value.
Compared to 1 year ago, CHCT has more shares outstanding
The number of shares outstanding for CHCT has been increased compared to 5 years ago.
Compared to 1 year ago, CHCT has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of 0.80, we must say that CHCT is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CHCT (0.80) is better than 67.19% of its industry peers.
A Debt/Equity ratio of 1.25 is on the high side and indicates that CHCT has dependencies on debt financing.
CHCT's Debt to Equity ratio of 1.25 is in line compared to the rest of the industry. CHCT outperforms 51.56% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 0.8 |
ROIC/WACC0.34
WACC6.71%
2.3 Liquidity
A Current Ratio of 0.47 indicates that CHCT may have some problems paying its short term obligations.
CHCT has a worse Current ratio (0.47) than 82.03% of its industry peers.
CHCT has a Quick Ratio of 0.47. This is a bad value and indicates that CHCT is not financially healthy enough and could expect problems in meeting its short term obligations.
CHCT has a worse Quick ratio (0.16) than 92.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.16 |
3. Growth
3.1 Past
The earnings per share for CHCT have decreased strongly by -146.88% in the last year.
The earnings per share for CHCT have been decreasing by -10.22% on average. This is quite bad
The Revenue for CHCT has decreased by -17.52% in the past year. This is quite bad
CHCT shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.73% yearly.
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
3.2 Future
CHCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 42.04% yearly.
CHCT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.35% yearly.
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue Next Year4.74%
Revenue Next 2Y5.36%
Revenue Next 3Y6.45%
Revenue Next 5Y9.35%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for CHCT. In the last year negative earnings were reported.
CHCT is valuated quite expensively with a Price/Forward Earnings ratio of 33.27.
Based on the Price/Forward Earnings ratio, CHCT is valued a bit cheaper than 71.88% of the companies in the same industry.
CHCT's Price/Forward Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 23.46.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 33.27 |
4.2 Price Multiples
CHCT's Enterprise Value to EBITDA ratio is in line with the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 13.8 |
4.3 Compensation for Growth
CHCT's earnings are expected to grow with 42.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y51.09%
EPS Next 3Y42.04%
5. Dividend
5.1 Amount
CHCT has a Yearly Dividend Yield of 11.95%, which is a nice return.
Compared to an average industry Dividend Yield of 6.43, CHCT pays a better dividend. On top of this CHCT pays more dividend than 96.88% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.00, CHCT pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.95% |
5.2 History
The dividend of CHCT has a limited annual growth rate of 2.99%.
CHCT has paid a dividend for at least 10 years, which is a reliable track record.
CHCT has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)2.99%
Div Incr Years9
Div Non Decr Years9
5.3 Sustainability
The earnings of CHCT are negative and hence is the payout ratio. CHCT will probably not be able to sustain this dividend level.
CHCT's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP-507.68%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
15.95
+0.18 (+1.14%)
Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)
Earnings (Next)
Inst Owners83.43%
Inst Owner Change-3.3%
Ins Owners5.89%
Ins Owner Change3.87%
Market Cap454.10M
Revenue(TTM)119.55M
Net Income(TTM)-10.49M
Analysts81.82
Price Target18.16 (13.86%)
Short Float %3.09%
Short Ratio2.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 11.95% |
Yearly Dividend1.85
Dividend Growth(5Y)2.99%
DP-507.68%
Div Incr Years9
Div Non Decr Years9
Ex-Date
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.89%
Min EPS beat(2)-88.54%
Max EPS beat(2)-63.24%
EPS beat(4)0
Avg EPS beat(4)-63.43%
Min EPS beat(4)-88.54%
Max EPS beat(4)-43.98%
EPS beat(8)0
Avg EPS beat(8)-53.34%
EPS beat(12)1
Avg EPS beat(12)-60.44%
EPS beat(16)1
Avg EPS beat(16)-48.6%
Revenue beat(2)0
Avg Revenue beat(2)-1.38%
Min Revenue beat(2)-2.49%
Max Revenue beat(2)-0.28%
Revenue beat(4)0
Avg Revenue beat(4)-1.73%
Min Revenue beat(4)-3.64%
Max Revenue beat(4)-0.28%
Revenue beat(8)0
Avg Revenue beat(8)-3.34%
Revenue beat(12)1
Avg Revenue beat(12)-2.84%
Revenue beat(16)1
Avg Revenue beat(16)-2.68%
PT rev (1m)-0.56%
PT rev (3m)-6.81%
EPS NQ rev (1m)37.5%
EPS NQ rev (3m)37.5%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.63%
Revenue NY rev (1m)0.23%
Revenue NY rev (3m)0.23%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 33.27 | ||
| P/S | 3.8 | ||
| P/FCF | N/A | ||
| P/OCF | 8.02 | ||
| P/B | 1.06 | ||
| P/tB | 1.07 | ||
| EV/EBITDA | 13.8 |
EPS(TTM)-0.15
EYN/A
EPS(NY)0.48
Fwd EY3.01%
FCF(TTM)-0.24
FCFYN/A
OCF(TTM)1.99
OCFY12.46%
SpS4.2
BVpS14.99
TBVpS14.94
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -1.06% | ||
| ROE | -2.46% | ||
| ROCE | 2.88% | ||
| ROIC | 2.27% | ||
| ROICexc | 2.28% | ||
| ROICexgc | 2.32% | ||
| OM | 23.26% | ||
| PM (TTM) | N/A | ||
| GM | 80.68% | ||
| FCFM | N/A |
ROA(3y)0.71%
ROA(5y)1.48%
ROE(3y)1.2%
ROE(5y)2.39%
ROIC(3y)2.59%
ROIC(5y)2.93%
ROICexc(3y)2.61%
ROICexc(5y)2.94%
ROICexgc(3y)2.69%
ROICexgc(5y)3%
ROCE(3y)3.28%
ROCE(5y)3.7%
ROICexgc growth 3Y-9.66%
ROICexgc growth 5Y-0.75%
ROICexc growth 3Y-10.19%
ROICexc growth 5Y-1.2%
OM growth 3Y-9.56%
OM growth 5Y-2.62%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5Y0.1%
F-Score3
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.25 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 7.48 | ||
| Cap/Depr | 145.76% | ||
| Cap/Sales | 53.07% | ||
| Interest Coverage | 1.1 | ||
| Cash Conversion | 79.35% | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.47 | ||
| Quick Ratio | 0.16 | ||
| Altman-Z | 0.8 |
F-Score3
WACC6.71%
ROIC/WACC0.34
Cap/Depr(3y)284.94%
Cap/Depr(5y)339.12%
Cap/Sales(3y)99.29%
Cap/Sales(5y)115.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-146.88%
EPS 3Y-37.5%
EPS 5Y-10.22%
EPS Q2Q%-25%
EPS Next Y-216.57%
EPS Next 2Y51.09%
EPS Next 3Y42.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.52%
Revenue growth 3Y8.53%
Revenue growth 5Y13.73%
Sales Q2Q%4.88%
Revenue Next Year4.74%
Revenue Next 2Y5.36%
Revenue Next 3Y6.45%
Revenue Next 5Y9.35%
EBIT growth 1Y-32.49%
EBIT growth 3Y-1.85%
EBIT growth 5Y10.76%
EBIT Next Year265.38%
EBIT Next 3Y62.68%
EBIT Next 5YN/A
FCF growth 1Y92.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-9.45%
OCF growth 3Y1.48%
OCF growth 5Y12.72%
COMMUNITY HEALTHCARE TRUST I / CHCT FAQ
What is the fundamental rating for CHCT stock?
ChartMill assigns a fundamental rating of 3 / 10 to CHCT.
What is the valuation status of COMMUNITY HEALTHCARE TRUST I (CHCT) stock?
ChartMill assigns a valuation rating of 2 / 10 to COMMUNITY HEALTHCARE TRUST I (CHCT). This can be considered as Overvalued.
How profitable is COMMUNITY HEALTHCARE TRUST I (CHCT) stock?
COMMUNITY HEALTHCARE TRUST I (CHCT) has a profitability rating of 3 / 10.
What is the expected EPS growth for COMMUNITY HEALTHCARE TRUST I (CHCT) stock?
The Earnings per Share (EPS) of COMMUNITY HEALTHCARE TRUST I (CHCT) is expected to decline by -216.57% in the next year.